Epimed International, Inc.

Epimed International, Inc. , based in the US, develops and manufactures specialized medical devices, including needles and catheters for Pain Medicine and Regional Anesthesia procedures, aimed at improving patient care outcomes. Epimed International, Inc. focuses on producing high-quality medical devices for pain management.

The company is headquartered in Dallas, US. Founded by industry professionals, Epimed has evolved its product offerings to meet the diverse needs of healthcare providers. Epimed International specializes in the manufacturing of high-quality needles and catheters for Pain Medicine and Regional Anesthesia procedures. Their core product offerings encompass a comprehensive range of catheter systems, including the Racz® Catheters and the G-21 Epidural Catheter™, designed for precision access in epidural spaces.

Additionally, they provide various nerve block needles, radiofrequency devices, and accessories that facilitate effective pain management procedures. These products are engineered to meet the needs of healthcare providers, such as anesthesiologists and pain management specialists, who require reliable and effective tools to deliver patient care. Epimed's products are distributed across multiple geographical markets, focusing on North America, Europe, and select regions in Asia, catering to medical professionals in hospitals and specialized pain management clinics. Epimed International generates revenue through direct sales of its medical devices and supplies to healthcare facilities and professionals, primarily through a B2B model.

Transactions typically occur via bulk orders, where healthcare providers purchase products such as the TUN-L Series Racz Catheters and the RX Epidural Needles for use in pain management procedures. The pricing structure reflects the specialized nature of the products, with different tiers based on the type and complexity of the devices. Additionally, Epimed offers customized solutions and OEM manufacturing services, enhancing transactional opportunities with clients who may require tailored products. These business dealings are supported by the company's commitment to quality and innovation in the pain medicine sector.